The Management of Lymphoma in the Setting of Pregnancy
- PMID: 28470380
- PMCID: PMC5650107
- DOI: 10.1007/s11899-017-0386-x
The Management of Lymphoma in the Setting of Pregnancy
Abstract
The diagnosis of lymphoma in pregnant patients poses a therapeutic challenge necessitating consideration of the developing fetus without compromise of therapy with curative potential for the mother. The decision to initiate therapy during pregnancy is heavily influenced by fetal, maternal, and disease-related factors, of which the most influential are the trimester at diagnosis, the stage, and aggressiveness of the disease and the presence of life-threatening symptoms. Recent data suggest that deferral of therapy until after the first trimester is desirable if it is perceived that postponement of therapy will not compromise maternal outcome. For some patients, delay of therapy to the postpartum period is feasible.
Keywords: Hodgkin lymphoma; Lymphoma; Pregnancy; Therapy.
Conflict of interest statement
Chelsea C Pinnix, Therese Y. Andraos, Sarah Milgrom and, Michelle A. Fanale each declare no potential conflicts of interest.
Figures
References
-
- Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7:279–287. - PubMed
-
- Van Calsteren K, Heyns L, De Smet F, et al. Cancer During Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes. Journal of Clinical Oncology. 2010;28:683–689. - PubMed
-
- Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med. 2015;373:1824–1834. - PubMed
-
- Engert A, Plutschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med. 2010;363:640–652. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
